A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study.
about
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol.Persistence to Treatment with Novel Antidiabetic Drugs (Dipeptidyl Peptidase-4 Inhibitors, Sodium-Glucose Co-Transporter-2 Inhibitors, and Glucagon-Like Peptide-1 Receptor Agonists) in People with Type 2 Diabetes: A Nationwide Cohort Study
P2860
A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A Class Comparison of Medicati ...... ospective Observational Study.
@en
A Class Comparison of Medicati ...... ospective Observational Study.
@nl
type
label
A Class Comparison of Medicati ...... ospective Observational Study.
@en
A Class Comparison of Medicati ...... ospective Observational Study.
@nl
prefLabel
A Class Comparison of Medicati ...... ospective Observational Study.
@en
A Class Comparison of Medicati ...... ospective Observational Study.
@nl
P2093
P2860
P1433
P1476
A Class Comparison of Medicati ...... ospective Observational Study.
@en
P2093
Martin Whyte
Neil Munro
Silvio Calderara
William Hinton
P2860
P2888
P304
P356
10.1007/S13300-017-0361-5
P577
2018-01-04T00:00:00Z